Clascoterone Cream (Winlevi) for Acne

Date: December 27, 2021 Issue #:  1640Summary:  The FDA has approvedWinlevi (Sun), a 1% cream formulation of the androgen receptor inhibitor clascoterone, for treatment of acne vulgaris in patients ≥12 years old. It is the first topical androgen receptor inhibitor to be approved by the FDA.
Source: The Medical Letter - Category: Drugs & Pharmacology Authors: Tags: Acanya Acne Aczone Adapalene Aklief Altreno Amzeeq Antibacterials Arazlo Atralin Avita Azelaic acid Azelex Benzaclin Benzamycin Benzoyl peroxide Biacna clascoterone Cleocin Clindamycin Clindoxy Dalacin Dapsone Source Type: research